EXPANDED ACCESS DATA IMPACT ON NDAs SHOULD BE ASSESSED BY FDA, REFORM BILL CONFERENCE REPORT STATES; "FAST TRACK" PROVISIONS CODIFY ACCELERATED APPROVAL
• By The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".